Voice Feature Analysis May Predict Incipient Heart Disease
|
By Daniel Beris Posted on 30 Nov 2016 |
|
Image: Human voice features could help identify heart disease (Photo courtesy of Beyond Verbal).
A new study suggests a strong correlation between some voice characteristics and the presence of coronary artery disease (CAD).
Researchers at Beyond Verbal (Tel Aviv, Israel) and the Mayo Clinic (Rochester, MN, USA), conducted a double-blind study involving 150 patients, including 120 patients who presented for coronary angiography, 21 apparently healthy control volunteers, and 9 control subjects who were referred to non-cardiac procedures. All subjects had their voice signal recorded prior to coronary angiography using the Beyond Verbal app, downloaded to their personal smartphone device.
Voice was then analyzed for multiple pre-specified features of intensity and frequency by different analytic tools. A total of three 30-second separate baseline voice recordings were documented and analyzed for each participant; first, the participant was asked to read a text; second, the participant was asked to describe a positive experience; and third, the participant was asked to describe a negative experience. Mel Frequency Cepstral Coefficients (MFCCs) were used in order to extract features from the voice signal.
The results identified 13 voice features that were associated with CAD. Stepwise binary logistic regression, with adjustment for age and gender, identified one voice feature that was associated with a 19-fold increased likelihood of CAD. With adjustment for age, gender, and cardiovascular risk factors, this feature was independently associated with a significant 2.6-fold increased likelihood of CAD. The study was presented as a poster session at the American Heart Association (AHA) scientific sessions, held during November 2016 in New Orleans (LA, USA).
“One voice characteristic in particular indicated an almost 20-fold increase in the likelihood of CAD. Since such voice characteristics can even be identified over a phone call, it is even feasible that people will be screened for CAD over the phone,” concluded lead author Elad Maor, MD, PhD, and colleagues of the Mayo Clinic. “Beyond that, identifying more voice biomarkers can produce a comprehensive test that would identify the possibility of a number of different conditions.”
“A patient’s voice is the most readily available, easy to capture, and rich output the body offers. We are very excited to be able to work with Mayo Clinic on such a breakthrough research, studying the potential of using the human voice in healthcare monitoring, and specifically cardiovascular disease,” said Yuval Mor, CEO of Beyond Verbal.
Related Links:
Beyond Verbal
Mayo Clinic
Researchers at Beyond Verbal (Tel Aviv, Israel) and the Mayo Clinic (Rochester, MN, USA), conducted a double-blind study involving 150 patients, including 120 patients who presented for coronary angiography, 21 apparently healthy control volunteers, and 9 control subjects who were referred to non-cardiac procedures. All subjects had their voice signal recorded prior to coronary angiography using the Beyond Verbal app, downloaded to their personal smartphone device.
Voice was then analyzed for multiple pre-specified features of intensity and frequency by different analytic tools. A total of three 30-second separate baseline voice recordings were documented and analyzed for each participant; first, the participant was asked to read a text; second, the participant was asked to describe a positive experience; and third, the participant was asked to describe a negative experience. Mel Frequency Cepstral Coefficients (MFCCs) were used in order to extract features from the voice signal.
The results identified 13 voice features that were associated with CAD. Stepwise binary logistic regression, with adjustment for age and gender, identified one voice feature that was associated with a 19-fold increased likelihood of CAD. With adjustment for age, gender, and cardiovascular risk factors, this feature was independently associated with a significant 2.6-fold increased likelihood of CAD. The study was presented as a poster session at the American Heart Association (AHA) scientific sessions, held during November 2016 in New Orleans (LA, USA).
“One voice characteristic in particular indicated an almost 20-fold increase in the likelihood of CAD. Since such voice characteristics can even be identified over a phone call, it is even feasible that people will be screened for CAD over the phone,” concluded lead author Elad Maor, MD, PhD, and colleagues of the Mayo Clinic. “Beyond that, identifying more voice biomarkers can produce a comprehensive test that would identify the possibility of a number of different conditions.”
“A patient’s voice is the most readily available, easy to capture, and rich output the body offers. We are very excited to be able to work with Mayo Clinic on such a breakthrough research, studying the potential of using the human voice in healthcare monitoring, and specifically cardiovascular disease,” said Yuval Mor, CEO of Beyond Verbal.
Related Links:
Beyond Verbal
Mayo Clinic
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Vessel Sealing Instrument
ERGOseal
New
Pediatric Mask
Respire SOFT
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
